InvestorsHub Logo
icon url

commoncentsinvestor

12/23/17 3:22 PM

#7387 RE: Lunacy_John Galt #7386

Well, it's been 11 months since I "discovered" VCEL and so far my opinion hasn't changed. With respect to UPSIDE POTENTIAL versus DOWNSIDE RISK, I believe it to be the most undervalued stock in the market.

Anyone who dabbles in small cap biotechs who does not own Vericel is missing a very sure bet. Most others with VCEL's market cap have little or no revenue and are spending big time to try to get an FDA approval.

Here we are with 2 FDA approved important products, a 3rd potential blockbuster, and substantial revenues that will only increase exponentially. I believe our rewards may possibly exceed even our fondest expectations.

Happy Holidays to all and best wishes for a most rewarding 2018.